|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.44 CNY | +1.76% |
|
+0.32% | -25.26% |
Shandong Keyuan Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 442.87 million. Net income was CNY 91.28 million.
Basic earnings per share from continuing operations was CNY 1.1214. Diluted earnings per share from continuing operations was CNY 1.1.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.26% | 380M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
SHANDONG KEYUAN PHARMACEUTICAL CO., LTD. 
